| 1 |
35478958 | Hesperidin Ameliorates Dexamethasone-Induced Osteoporosis by Inhibiting p53. | 2022 |
2 |
| 2 |
32272509 | Dexamethasone Interferes with Autophagy and Affects Cell Survival in Irradiated Malignant Glioma Cells. | 2020 Sep |
1 |
| 3 |
33425404 | Efficacy of Venetoclax and Dexamethasone in Refractory IgM Primary Plasma Cell Leukemia with t(11;14) and TP53 Mutation: A Case Report and Literature Review. | 2020 |
1 |
| 4 |
30375484 | Chronic p27Kip1 Induction by Dexamethasone Causes Senescence Phenotype and Permanent Cell Cycle Blockade in Lung Adenocarcinoma Cells Over-expressing Glucocorticoid Receptor. | 2018 Oct 30 |
1 |
| 5 |
28755014 | Significance of glucocorticoid receptor expression in patients with non-small cell lung cancer treated with pemetrexed-based chemotherapy. | 2017 Oct |
1 |
| 6 |
28918747 | Omega-3 Polyunsaturated Fatty Acids Eicosapentaenoic Acid and Docosahexaenoic Acid Enhance Dexamethasone Sensitivity in Multiple Myeloma Cells by the p53/miR-34a/Bcl-2 Axis. | 2017 Jul |
4 |
| 7 |
23727633 | Glucocorticoids induce senescence in primary human tenocytes by inhibition of sirtuin 1 and activation of the p53/p21 pathway: in vivo and in vitro evidence. | 2014 Jul |
4 |
| 8 |
24736075 | Glucocorticoid receptor status is a principal determinant of variability in the sensitivity of non-small-cell lung cancer cells to pemetrexed. | 2014 Apr |
2 |
| 9 |
23759586 | Attenuation of dexamethasone-induced cell death in multiple myeloma is mediated by miR-125b expression. | 2013 Jul 1 |
3 |
| 10 |
22773829 | Glucocorticoid receptor activation inhibits p53-induced apoptosis of MCF10Amyc cells via induction of protein kinase Cε. | 2012 Aug 24 |
1 |
| 11 |
23272171 | Dexamethasone reduces sensitivity to cisplatin by blunting p53-dependent cellular senescence in non-small cell lung cancer. | 2012 |
3 |
| 12 |
20878126 | Thalidomide enhances cyclophosphamide and dexamethasone-mediated cytotoxicity towards cultured chronic lymphocytic leukaemia cells. | 2010 Nov |
1 |
| 13 |
12519780 | Identification of a functional link for the p53 tumor suppressor protein in dexamethasone-induced growth suppression. | 2003 Mar 14 |
3 |
| 14 |
14555213 | Pleiotropic anti-apoptotic activity of glucocorticoids in ovarian follicular cells. | 2003 Oct 15 |
2 |
| 15 |
11139340 | p53-independent upregulation of KILLER/DR5 TRAIL receptor expression by glucocorticoids and interferon-gamma. | 2001 Jan 15 |
1 |
| 16 |
11159853 | Glucocorticoids protect against apoptosis induced by serum deprivation, cyclic adenosine 3',5'-monophosphate and p53 activation in immortalized human granulosa cells: involvement of Bcl-2. | 2001 Feb |
4 |
| 17 |
11295047 | Synergistic effects of dexamethasone and genistein on the expression of Cdk inhibitor p21WAF1/CIP1 in human hepatocellular and colorectal carcinoma cells. | 2001 May |
1 |
| 18 |
11350911 | Enforced expression of wild-type p53 curtails the transcription of the O(6)-methylguanine-DNA methyltransferase gene in human tumor cells and enhances their sensitivity to alkylating agents. | 2001 May |
3 |
| 19 |
11498783 | Tissue specific expression of p53 target genes suggests a key role for KILLER/DR5 in p53-dependent apoptosis in vivo. | 2001 Aug 2 |
2 |
| 20 |
11562347 | Ligand-dependent interaction of the glucocorticoid receptor with p53 enhances their degradation by Hdm2. | 2001 Sep 15 |
5 |
| 21 |
11677114 | Steroid-mediated inhibition of radiation-induced apoptosis in C4-1 cervical carcinoma cells is p53-dependent. | 2001 Nov |
1 |
| 22 |
10654447 | Polyamine-depletion induces p27Kip1 and enhances dexamethasone-induced G1 arrest and apoptosis in human T lymphoblastic leukemia cells. | 2000 Feb |
1 |
| 23 |
10817508 | Inhibition of radiation-induced apoptosis by dexamethasone in cervical carcinoma cell lines depends upon increased HPV E6/E7. | 2000 May |
2 |
| 24 |
11080152 | Negative cross-talk between p53 and the glucocorticoid receptor and its role in neuroblastoma cells. | 2000 Nov 15 |
1 |
| 25 |
10413457 | Ser/Thr protein phosphatase type 5 (PP5) is a negative regulator of glucocorticoid receptor-mediated growth arrest. | 1999 Jul 13 |
1 |
| 26 |
10597242 | Induction of the TRAIL receptor KILLER/DR5 in p53-dependent apoptosis but not growth arrest. | 1999 Nov 11 |
1 |
| 27 |
9516963 | Selective sensitization to DNA-damaging agents in a human rhabdomyosarcoma cell line with inducible wild-type p53 overexpression. | 1998 Jan |
1 |
| 28 |
9664139 | Bcl-2 overexpression is associated with resistance to dexamethasone, but not melphalan, in multiple myeloma cells. | 1998 Aug |
1 |
| 29 |
9685342 | Stabilization of p53 by adenovirus E1A occurs through its amino-terminal region by modification of the ubiquitin-proteasome pathway. | 1998 Aug 7 |
2 |
| 30 |
9794234 | Dexamethasone-mediated protection from drug cytotoxicity: association with p21WAF1/CIP1 protein accumulation? | 1998 Sep 24 |
10 |
| 31 |
9058378 | Repression of glucocorticoid receptor transactivation and DNA binding of a glucocorticoid response element within the serum/glucocorticoid-inducible protein kinase (sgk) gene promoter by the p53 tumor suppressor protein. | 1997 Mar |
3 |
| 32 |
9191791 | Chemotherapy of human malignant glioma: prevention of efficacy by dexamethasone? | 1997 Jun |
1 |
| 33 |
8806692 | p53-independent growth regulation of cervical cancer cells by the papillomavirus E6 oncogene. | 1996 Sep 5 |
1 |
| 34 |
8931502 | Cytologic changes in two cervical carcinoma cell lines after transfection of the wild-type p53 gene. | 1996 Oct |
3 |
| 35 |
8986612 | Intranuclear redistribution of SV40T, p53, and PML in a conditionally SV40T-immortalized cell line. | 1996 Dec 15 |
1 |
| 36 |
21541525 | bcl-2 plays a major role in resistance to dexamethasone induced apoptosis in multiple myeloma cell lines. | 1996 Aug |
5 |
| 37 |
21544419 | The role of p53, bcl-2 and bax network in dexamethasone induced apoptosis in multiple myeloma cell lines. | 1996 Apr |
8 |
| 38 |
7730147 | Inhibition by differentiation-inducing agents of wild-type p53-dependent apoptosis in HL-60 cells. | 1995 Feb |
4 |
| 39 |
7936649 | The carboxy-terminal serine 392 phosphorylation site of human p53 is not required for wild-type activities. | 1994 Nov |
1 |
| 40 |
8151752 | Reversible repression of papillomavirus oncogene expression in cervical carcinoma cells: consequences for the phenotype and E6-p53 and E7-pRB interactions. | 1994 May |
1 |
| 41 |
8117626 | Wild-type p53 tumor suppressor gene restores differentiation of human squamous carcinoma cells but not the response to transforming growth factor beta. | 1993 Dec |
3 |
| 42 |
1459195 | Effects of exogenous wild-type p53 on a human lung carcinoma cell line with endogenous wild-type p53. | 1992 Dec |
3 |